University of Texas Southwestern
University of Texas Southwestern
Dallas, Texas, United States16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EVERO Drug-coated Balloon (DCB) Randomized Trial | Arterial Occlusive Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2026-09-29 | NCT07144150 | |
| An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, pulmonary emphysema, respiratory system disorder | Recruiting | Not applicable | 2026-09-17 | NCT06035120 | |
| Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT | Head and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasm | Recruiting | Not applicable | 2026-09-04 | NCT05442957 | |
| Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy | Muscular dystrophy congenital, merosin negative | Recruiting | Not stated | 2026-08-19 | NCT06503367 | |
| Once Weekly Infant Corticosteroid Trial for DMD | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 4 | 2026-08-14 | NCT05412394 | |
| Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Not stated | 2026-08-12 | NCT01915511 | |
| Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission | Crohn disease, Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Not applicable | 2026-08-07 | NCT05230173 | |
| A Study of ASP1002 in Adults for Treatment of Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Recruiting | Phase 1 | 2026-07-23 | NCT05719558 | |
| NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-07-20 | NCT06450041 | |
| Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Tumor Virus Infections, adenocarcinoma, basal cell carcinoma, basal cell neoplasm, cancer, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, skin disorder, skin neoplasm, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-22 | NCT04349436 | |
| Neuroblastoma Biology Study | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not stated | 2026-03-23 | NCT01587300 | |
| Long-Term Follow-up Study | B-cell neoplasm, B-cell non-Hodgkin lymphoma, Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, cardiovascular disorder, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myeloid leukemia, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Enrolling by invitation | Not stated | 2026-03-12 | NCT05332054 | |
| PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound Infection, Wound Infection | Active, not recruiting | Phase 4 | 2026-02-04 | NCT05763602 | |
| Pediatric Dose Optimization for Seizures in Emergency Medical Services | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2025-09-30 | NCT05121324 | |
| Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, blood platelet disease, cardiovascular disorder, coagulation protein disease, hematologic disorder, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, vascular disorder, vascular hemostatic disease, von Willebrand disease (hereditary or acquired) | Recruiting | Phase 1 / Phase 2 | 2025-08-26 | NCT05776069 | |
| Study of SGR-3515 In Participants With Advanced Solid Tumors. | Advanced Solid Tumor | Recruiting | Phase 1 | 2025-08-01 | NCT06463340 |